Patents by Inventor Jacques Paris

Jacques Paris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10123096
    Abstract: Systems and methods for maximizing the resonance frequency match between a reader and a controlled device interacting over a narrowband inductive link involve, in various embodiments, features of the controlled device, the reader, or both.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: November 6, 2018
    Assignee: MINIPUMPS, LLC
    Inventors: Jacques Paris, Didier Sagan
  • Publication number: 20170034601
    Abstract: Systems and methods for maximizing the resonance frequency match between a reader and a controlled device interacting over a narrowband inductive link involve, in various embodiments, features of the controlled device, the reader, or both.
    Type: Application
    Filed: October 14, 2016
    Publication date: February 2, 2017
    Inventors: Jacques PARIS, Didier Sagan
  • Patent number: 9489549
    Abstract: Systems and methods for maximizing the resonance frequency match between a reader and a controlled device interacting over a narrowband inductive link involve, in various embodiments, features of the controlled device, the reader, or both.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: November 8, 2016
    Assignee: MiniPumps, LLC
    Inventors: Jacques Paris, Didier Sagan
  • Publication number: 20160042205
    Abstract: Systems and methods for maximizing the resonance frequency match between a reader and a controlled device interacting over a narrowband inductive link involve, in various embodiments, features of the controlled device, the reader, or both.
    Type: Application
    Filed: August 5, 2015
    Publication date: February 11, 2016
    Inventors: Jacques Paris, Didier Sagan
  • Patent number: 9084796
    Abstract: A method of preventing estrogen deficiencies and osteoporosis in menopausal women by continuously orally administering without interruption to menopausal women in need thereof an amount of 0.3 to 3 mg of 17?-estradiol or esters thereof and 0.3 to 1.25 mg of nomegestrol or esters thereof in an amount sufficient to prevent said problems.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: July 21, 2015
    Assignee: LABORATOIRE THERAMEX
    Inventors: Jacques Paris, Jean-Louis Thomas
  • Publication number: 20130172300
    Abstract: A method of preventing estrogen deficiencies and osteoporosis in menopausal women by continuously orally administering without interruption to menopausal women in need thereof an amount of 0.3 to 3 mg of 17?-estradiol or esters thereof and 0.3 to 1.25 mg of nomegestrol or esters thereof in an amount sufficient to prevent said problems.
    Type: Application
    Filed: April 17, 2012
    Publication date: July 4, 2013
    Inventors: Jacques Paris, Jean-Louis Thomas
  • Patent number: 8168619
    Abstract: A method of preventing estrogen deficiencies and osteoporosis in menopausal women by continuously orally administering without interruption to menopausal women in need thereof an amount of 0.3 to 3 mg of 17?-estradiol or esters thereof and 0.3 to 1.25 mg of nomegestrol or esters thereof in an amount sufficient to prevent said problems.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: May 1, 2012
    Assignee: Laboratoire Theramex
    Inventors: Jacques Paris, Jean-Louis Thomas
  • Patent number: 7749987
    Abstract: A method of achieving contraception in a woman which comprises administering orally to said woman an estroprogestative composition comprising nomegestrol acetate and an estrogen is provided.
    Type: Grant
    Filed: January 3, 2007
    Date of Patent: July 6, 2010
    Assignee: Laboratorie Theramek
    Inventors: Jacques Paris, Jean-Louis Thomas, Michel Lanquetin, Anny Lanquetin, legal representative, Jean-Philippe Lanquetin, legal representative
  • Patent number: 7500623
    Abstract: A process for the milling of a nuclear graphite contaminated with radioelements includes subjecting the graphite, immersed in a liquid medium, to high-voltage pulses. The liquid medium has a resistivity such that, owing to the effect of the energy conveyed by the said pulses, electric arcs are initiated and, upon contact with the graphite, break the carbon-carbon bonds that make up the graphite. The number of high-voltage pulses is set so as to obtain a given particle size.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: March 10, 2009
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jacques Paris, Jean-Raymond Costes
  • Patent number: 7465377
    Abstract: A process for the treatment of a nuclear graphite contaminated with radioelements includes subjecting the graphite, immersed in a medium containing water, to high-voltage pulses. The pulses have sufficient energy for electric arcs to be initiated and to break the constituent bonds of the water molecules and the carbon-carbon bonds of the graphite. The number of high-voltage pulses is determined so as to convert the graphite into gas.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: December 16, 2008
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jacques Paris, Jean-Raymond Costes
  • Publication number: 20080227763
    Abstract: The present invention relates to the area of chemotherapy and more especially to the development of new galenic forms for application to the skin. It relates more particularly to a topical hormonal composition with systemic action for the correction of progesterone deficiency in premenopausal women and for hormone replacement in menopausal women, characterized in that it contains, as the active principle, a progestogen derived from 19-nor progesterone, a vehicle permitting systemic passage of the said active principle chosen from the group comprising a solubilizing agent, an absorption promoter, a film-forming agent, a gelling agent or their mixtures, combined with or mixed with suitable excipients for production of a pharmaceutical form as a gel and/or a film.
    Type: Application
    Filed: March 20, 2008
    Publication date: September 18, 2008
    Inventors: Michel Lanquetin, Jacques Paris, Jean-Louis Thomas
  • Publication number: 20080027794
    Abstract: A bicycle including an impact detection device and a monitoring central processing unit connected to said impact detection device.
    Type: Application
    Filed: July 23, 2007
    Publication date: January 31, 2008
    Applicant: JCDecaux SA
    Inventors: Jacques Le Gars, Jacques Paris, Patrick Tavernier
  • Publication number: 20070281912
    Abstract: A method of achieving contraception in a woman which comprises administering orally to said woman an estroprogestative composition comprising nomegestrol acetate and an estrogen is provided.
    Type: Application
    Filed: January 3, 2007
    Publication date: December 6, 2007
    Inventors: Jacques Paris, Jean-Louis Thomas, Michel Lanquetin, Anny Lanquetin, Jean-Philippe Lanquetin
  • Patent number: 7030104
    Abstract: The present invention relates to the field of therapeutic chemistry and more especially to the realization of new galenic forms intended to be applied on the skin. More particularly it relates to a topical hormonal composition with a systemic effect for the hormonal treatment of the perimenopause and of the menopause as well as for the treatment of the ovarian hormonal deficiencies in women with amenorrhea, characterized in that it comprises, as active ingredients, a progestogen derived from 19-nor progesterone and estradiol or one of its derivatives, a vehicle which allows the systemic passage of said active ingredients, chosen from the group constituted by a solubilizing agent, an absorption promoting agent, a film-forming agent, a gelling agent and their mixtures, in combination or in a mixture with suitable excipients for the realization of a gelled and/or film-forming pharmaceutical form.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: April 18, 2006
    Assignee: Laboratoire Theramex
    Inventors: Georges Gray, Bertrand Villet, Jacques Paris, Jean-Louis Thomas
  • Patent number: 6906049
    Abstract: The present invention relates to the field of chemistry and more particularly to that of therapeutic chemistry. The invention relates more particularly to novel contraceptive compositions formed from a progestative agent and an oestrogen. The invention relates specifically to novel pharmaceutical contraceptive compositions, characterized in that they contain, as active ingredients, a nomegestrol ester and oestradiol, in combination or admixture with an inert, non-toxic, pharmaceutically-acceptable vehicle or diluent which is suitable for oral administration.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: June 14, 2005
    Assignee: Laboratoire Theramex
    Inventors: Jacques Paris, Jean Louis Thomas
  • Publication number: 20050124842
    Abstract: A process for the treatment of a nuclear graphite contaminated with radioelements includes subjecting the graphite, immersed in a medium containing water, to high-voltage pulses. The pulses have sufficient energy for electric arcs to be initiated and to break the constituent bonds of the water molecules and the carbon-carbon bonds of the graphite. The number of high-voltage pulses is determined so as to convert the graphite into gas.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 9, 2005
    Inventors: Jacques Paris, Jean-Raymond Costes
  • Publication number: 20050051644
    Abstract: The invention relates to a process for the treatment of a nuclear graphite contaminated with radioelements, the said process comprising a milling step consisting in subjecting the said graphite, immersed in a liquid medium, to high-voltage pulses, the said liquid medium having a resistivity such that, owing to the effect of the energy conveyed by the said pulses, electric arcs are initiated and, upon contact with the said graphite, break the carbon-carbon bonds that make up this graphite, the number of high-voltage pulses being set so as to obtain a given particle size.
    Type: Application
    Filed: December 10, 2002
    Publication date: March 10, 2005
    Inventors: Jacques Paris, Jean-Raymond Costes
  • Patent number: 6831073
    Abstract: A method of treating estrogenic deficiencies in women while further avoiding the appearance of osteoporosis, withdrawal bleeding and cardiovascular diseases in post-menopausal women without any androgenic effect, and no deleterious effects on blood vessels comprising continuously without interruption administering to said women, a combination of 0.5 to 3 mg of an estrogenic compound and 1.5 to 3.75 mg of nomegestrol acetate.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: December 14, 2004
    Assignee: Laboratoire Theramex
    Inventors: Michel Lanquetin, Jacques Paris, Jean-Louis Thomas
  • Publication number: 20040220163
    Abstract: The present invention relates to a method of achieving contraception in a woman, comprising daily administering to said woman, from the first day of her cycle, a pharmaceutical composition comprising (i) estradiol, an ester thereof or an equine conjugated estrogen and (ii) nomegestrol acetate.
    Type: Application
    Filed: January 8, 2004
    Publication date: November 4, 2004
    Applicant: Laboratoire Theramex
    Inventors: Jacques Paris, Jean-Louis Thomas, Michel Lanquetin
  • Patent number: 6631020
    Abstract: The focal distance (f) of a laser (1) beam (2) is adjusted by projecting the beam (2) onto the center of a mirror (3) of variable curvature and controlled by a depression circuit or by electrostatic forces. Thus the focus (4) can be displaced in a direction which is inaccessible to the usual means such as turning but rigid mirrors.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: October 7, 2003
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jacques Paris, Patrick Rouannet